Results 181 to 190 of about 1,915,304 (214)
Some of the next articles are maybe not open access.

Drug‐Eluting Balloon Angioplasty for In‐Stent Restenosis Following Carotid Artery Stent Placement

Journal of Neuroimaging, 2020
Drug‐eluting balloons (DEBs) have been proposed as an option for the treatment of in‐stent restenosis (ISR) following carotid artery stent placement. We report our experience and review of literature to provide additional data.
Kunal Bhatia   +6 more
semanticscholar   +1 more source

Thirty-six-month outcomes of drug-eluting balloon angioplasty in the infrapopliteal arteries

open access: yesVascular, 2018
Objectives To evaluate 36-month outcomes of drug-eluting balloons in infrapopliteal (=below-the-knee) arterial segments, we made a prospective registry enrolling patients (Rutherford class 2 to 5, ankle–brachial index 0.4–0.7) who were revascularized ...
B. Ozpak, Ş. Bozok, M. Cayir
semanticscholar   +2 more sources

Hemodialysis Arteriovenous Fistula and Graft Stenoses: Randomized Trial Comparing Drug-eluting Balloon Angioplasty with Conventional Angioplasty.

Radiology, 2018
Purpose To compare lesion primary patency and restenosis rates between drug-eluting balloon (DEB) percutaneous transluminal angioplasty (PTA) and conventional balloon PTA (cPTA) in the treatment of arteriovenous fistula (AVF) and arteriovenous graft (AVG)
F. Irani   +13 more
semanticscholar   +1 more source

Prospective randomized single-blind multicenter study to assess the safety and effectiveness of the SELUTION SLR 014 drug eluting balloon in the treatment of subjects with in-stent restenosis: rationale and design.

American Heart Journal
BACKGROUND Repeat drug-eluting stenting is superior to balloon angioplasty for prevention of recurrent in-stent restenosis (ISR), but carries a potential disadvantage of multiple layers of stent.
D. Cutlip   +8 more
semanticscholar   +1 more source

Multicentre, randomised, blinded, control trial of drug-eluting balloon vs Sham in recurrent native dialysis fistula stenoses

Journal of Vascular Access, 2018
Background: Endovascular treatment of autogenous arteriovenous haemodialysis fistula stenosis has high reintervention rates. We investigate the effect of drug-eluting balloons in the treatment of recurrent haemodialysis fistula stenosis. Methods: This is
Jan Swinnen   +12 more
semanticscholar   +1 more source

Orbital atherectomy versus balloon angioplasty before drug-eluting stent implantation in severely calcified lesions eligible for both treatment strategies (ECLIPSE): a multicentre, open-label, randomised trial.

The Lancet
BACKGROUND Coronary artery calcification is common among patients undergoing percutaneous coronary intervention (PCI), and severe coronary artery lesion calcification is associated with increased procedural complexity, stent under-expansion, and high ...
Ajay J. Kirtane   +21 more
semanticscholar   +1 more source

Clinical Outcomes of Drug-Eluting Balloon for In-Stent Restenosis Based on the Number of Metallic Layers: The New Tokyo Registry

Circulation. Cardiovascular Interventions, 2018
Background: This study assesses clinical outcomes after drug-eluting balloon treatment for recurrent in-stent restenosis lesions based on the number of metallic layers.
H. Yabushita   +19 more
semanticscholar   +1 more source

Drug-Eluting Balloon for Below the Knee Angioplasty: Five-Year Outcome of the DEBATE-BTK Randomized Clinical Trial

Cardiovascular and Interventional Radiology, 2022
F. Liistro   +8 more
semanticscholar   +1 more source

Clinical outcomes of drug-eluting balloon for treatment of small coronary artery in patients with acute myocardial infarction

Internal and Emergency Medicine, 2021
Q. Tan   +4 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy